Brazil study suggests AstraZeneca vaccine is effective against Brazil COVID-19 variant


  • World
  • Tuesday, 09 Mar 2021

FILE PHOTO: Empty vials of AstraZeneca COVID-19 vaccine are seen in a tray during a mass vaccination campaign at Atletico Madrid's Wanda Metropolitano stadium in Madrid, Spain, February 25, 2021. REUTERS/Sergio Perez/File Photo

RIO DE JANEIRO (Reuters) - Preliminary studies suggest the AstraZeneca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil's Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday.

The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from the Latin American nation.

(Reporting by Rodrigo Viga)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In World

Brazil's Lula says U.S. will quickly recognize election result
Zelenskiy denounces Russian-staged votes; says there will be good news from the front
U.S. agricultural futures close mixed
Interview: Audi on course to capitalize on increasing demand in China
U.S. dollar edges up, sterling rebounds
Boeing delivers 100th 737-800 converted freighter to AerCap
Huawei holds European Innovation Day in Hungary
Zurich Film Festival shines spotlight on Chinese movies
U.S. stocks close mixed
Tourists visited Egypt hit 4.9 million in 1st half of 2022

Others Also Read